S100A8 and cancer: The massive release of S100A8/A9 from these sources will induce the elevation of plasma levels of S100A8/A9, resulting in the initiation of inflammatory responses as a damage-associated molecular pattern (DAMP) and the modulation of cancer metastasis as mentioned above.